Atara Biotherapeutics Ownership | Who Owns Atara Biotherapeutics?


OverviewForecastRevenueFinancialsChart

Atara Biotherapeutics Ownership Summary


Atara Biotherapeutics is owned by 20.44% institutional investors, 16.74% insiders, and 62.82% retail investors. Adage capital partners gp is the largest institutional shareholder, holding 5.58% of ATRA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.05% of its assets in Atara Biotherapeutics shares.

ATRA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAtara Biotherapeutics20.44%16.74%62.82%
SectorHealthcare Stocks 35.49%11.75%52.76%
IndustryBiotech Stocks 34.83%11.71%53.46%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Adage capital partners gp700.00K5.58%$3.31M
Redmile group441.70K3.52%$2.09M
Mackenzie financial313.62K2.50%$1.48M
Vanguard group225.94K1.67%$4.09M
Point72 asset management194.26K1.55%$918.87K
Acadian asset management130.91K1.04%$617.00K
Ecor1 capital99.59K0.79%$471.07K
Blackrock funding, inc. /de79.02K0.63%$373.77K
Geode capital management66.15K0.53%$313.05K
Ubs group50.07K0.40%$236.83K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Redmile group441.70K0.14%$2.09M
Ecor1 capital99.59K0.02%$471.07K
Staley capital advisers50.00K0.01%$236.50K
Adage capital partners gp700.00K0.01%$3.31M
Bridgeway capital management32.69K0.00%$154.63K
Mackenzie financial313.62K0.00%$1.48M
Point72 asset management194.26K0.00%$918.87K
Acadian asset management130.91K0.00%$617.00K
Sbi securities1.57K0.00%$7.45K
Vanguard group225.94K0.00%$4.09M

Top Buyers

HolderShares% AssetsChange
Adage capital partners gp700.00K0.01%700.00K
Mackenzie financial313.62K0.00%254.95K
Point72 asset management194.26K0.00%175.97K
Acadian asset management130.91K0.00%76.86K
Ubs group50.07K-48.67K

Top Sellers

HolderShares% AssetsChange
Blackrock---6.83M
Bank of america corp /de/---6.58M
Price t rowe associates inc /md/---4.96M
Aqr capital management---2.63M
Woodline partners lp---1.77M

New Positions

HolderShares% AssetsChangeValue
Adage capital partners gp700.00K0.01%700.00K$3.31M
Millennium management47.69K0.00%47.69K$225.57K
Vanguard fiduciary trust33.62K-33.62K$159.03K
Vanguard global advisers1.46K-1.46K$6.89K
Citigroup1.00-1.00$5.00

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-23.00
Eversource wealth advisors-35.00
Nisa investment advisors-50.00
Gamma investing-56.00
Point72 (difc)-68.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202633-21.43%2,564,23025.10%208.95%16-15.79%3-62.50%
Dec 31, 20257-81.08%379,045-79.87%21.17%3-81.25%1-85.71%
Sep 30, 20258-73.33%233,049-86.80%10.91%3-62.50%--100.00%
Jun 30, 202532-8.57%1,803,95019.18%147.48%11-8.33%6-53.85%
Mar 31, 202536-14.29%2,086,297-10.96%194.03%13-43.48%1318.18%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF120.26K2.05%-
Vanguard Total Stock Mkt Idx Inv158.65K1.94%-
Mackenzie GQE US Small Cap F8118.39K1.39%17.38K
Vanguard Institutional Extnd Mkt Idx Tr56.37K0.69%-
Fidelity Extended Market Index32.02K0.38%2.14K
Bridgeway Ultra-Small Company18.69K0.26%18.69K
Bridgeway Ultra-Small Company Market14.00K0.19%-
Fidelity VIP Disciplined Small Cap Init16.24K0.19%-
Fidelity Enhanced Small Cap ETF10.45K0.18%-
NT R2000 Value Index Fund - NL255.47K0.18%-

Recent Insider Transactions


DateNameRoleActivityValue
May 07, 2026Panacea Innovation Ltd-Sell$3.17M
May 07, 2026EcoR1 Capital, LLC-Buy$4.74M
Mar 02, 2026Grant-Huerta Yanina Chief Accounting OfficerSell$121.85
Mar 02, 2026Grant-Huerta Yanina Chief Accounting OfficerSell$8.14K
Mar 02, 2026Grant-Huerta Yanina Chief Accounting OfficerSell$1.92K

Insider Transactions Trends


DateBuySell
2026 Q1-9
2025 Q4-5
2025 Q326
2025 Q2-2
2025 Q1-3

ATRA Ownership FAQ


Who Owns Atara Biotherapeutics?

Atara Biotherapeutics shareholders are primarily institutional investors at 20.44%, followed by 16.74% insiders and 62.82% retail investors. The average institutional ownership in Atara Biotherapeutics's industry, Biotech Stocks , is 34.83%, which Atara Biotherapeutics falls below.

Who owns the most shares of Atara Biotherapeutics?

Atara Biotherapeutics’s largest shareholders are Adage capital partners gp (700K shares, 5.58%), Redmile group (441.7K shares, 3.52%), and Mackenzie financial (313.62K shares, 2.50%). Together, they hold 11.60% of Atara Biotherapeutics’s total shares outstanding.

Does Blackrock own Atara Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of Atara Biotherapeutics.

Who is Atara Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Redmile group is Atara Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 0.14% of its assets in 441.7K Atara Biotherapeutics shares, valued at 2.09M$.

Who is the top mutual fund holder of Atara Biotherapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Atara Biotherapeutics shares, with 2.05% of its total shares outstanding invested in 120.26K Atara Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools